Parkinson Disease Protein 7 Human Recombinant ( PARK7 Human )

Price range: $192.50 through $3,234.00

Novatein Biosciences provides Parkinson Disease Protein 7 Human Recombinant ( PARK7 Human ) also known as early onset) 7, Oncogene DJ-1, Parkinson disease (autosomal recessive, Parkinson disease protein 7, PARK7 for your R&D

SKU: PT_41689 Category:

Description

Data Sheet

Amino acid sequence MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMASK RALVILAKGA EEMETVIPVD VMRRAGIKVT VAGLAGKDPV QCSRDVVICP DASLEDAKKE GPYDVVVLPG GNLGAQNLSE SAAVKEILKE QENRKGLIAA ICAGPTALLA HEIGFGSKVT THPLAKDKMM NGGHYTYSEN RVEKDGLILT SRGPGTSFEF ALAIVEALNG KEVAAQVKAP LVLKD.
Description PARK7 Human Recombinant fused to an N-terminal 36 aa His-Tag, produced in E.Coli is a single, non-glycosylated polypeptide chain (aa 1-189) containing 225 amino acids and having a molecular mass of 24 kDa.
Expression host Escherichia Coli.
Formulation The protein solution (1mg/ml) contains 20mM Tris-HCl pH-8 and 20% glycerol.
Protein Background The PARK7 is a ubiquitously expressed protein involved in various cellular processes including spermatogenesis and fertilization, cancer, RNA-binding, androgen-receptor signaling and oxidative stress. Mutations in the PARK7 are the cause of autosomal recessive early-onset Parkinsons disease 7 (Park7).
Purity Greater than 95.0% as determined by SDS-PAGE.
Reagent Appearance Sterile Filtered colorless solution.
Stability Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Synonyms Protein DJ-1, Oncogene DJ1, Parkinson disease protein 7, PARK7, DJ1, DJ-1, FLJ27376.

Additional information

Size

5ug, 1mg, 20ug